A Proton‐Activatable DNA‐Based Nanosystem Enables Co‐Delivery of CRISPR/Cas9 and DNAzyme for Combined Gene Therapy-Reference-Cited by-同舟云学术

A Proton‐Activatable DNA‐Based Nanosystem Enables Co‐Delivery of CRISPR/Cas9 and DNAzyme for Combined Gene Therapy

Published:2022-01-18 Issue:9 Volume:134 Page:
ISSN:0044-8249
Container-title:Angewandte Chemie
language:en
Short-container-title:Angewandte Chemie

Author:

Li Feng¹,Song Nachuan¹,Dong Yuhang¹,Li Shuai¹,Li Linghui¹,Liu Yujie¹,Li Zhemian¹,Yang Dayong¹^ORCID

Affiliation:

1. Frontiers Science Center for Synthetic Biology Key Laboratory of Systems Bioengineering (MOE) Institute of Biomolecular and Biomedical Engineering School of Chemical Engineering and Technology Tianjin University Tianjin 300350 P.R. China

Funder

National Natural Science Foundation of China

Ministry of Science and Technology of the People's Republic of China

Natural Science Foundation of Tianjin City

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ange.202116569

Reference83 articles.

2. The new frontier of genome engineering with CRISPR-Cas9

3. Therapeutic genome editing: prospects and challenges

5. Codelivery of CRISPR-Cas9 and chlorin e6 for spatially controlled tumor-specific gene editing with synergistic drug effects

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Photoactivatable Engineering of CRISPR/Cas9‐Inducible DNAzyme Probe for In Situ Imaging of Nuclear Zinc Ions;Angewandte Chemie;2024-02-05

2. Photoactivatable Engineering of CRISPR/Cas9‐Inducible DNAzyme Probe for In Situ Imaging of Nuclear Zinc Ions;Angewandte Chemie International Edition;2024-02-05

3. Construction of rolling circle amplification products-based pure nucleic acid nanostructures for biomedical applications;Acta Biomaterialia;2023-04